As the opioid crisis worsens, one Boston-based pharmaceutical company has used some impressive biology to create a non-addictive, non-opioid painkiller. As the New York Times reports, Vertex Pharmaceuticals seems to have shown some extremely promising results in Phase 3 clinical trials, announced earlier this week in a statement, for patients who experienced "moderate-to-severe acute pain" after […]
A drug application for psychedelic-assisted therapies has been filed for FDA approval. Marine Corps veteran Juliana Mercer shares the benefits of the treatment, with doctors also weighing in.